Jerod Sears, MD
| Hometown: Lexington, KY |
| Medical School: Wake Forest |
| Residency: Washington University in St. Louis/Barnes-Jewish Hospital |
| Research/Academic Interests: Liquid biopsy and minimal disease detection in solid malignancies, clinical trials, cancer genomics |
| Bio: I enjoy going to the many restaurants and breweries in St. Louis and maintain a power ranking of my favorite spots. I also like going to Cardinals baseball games, the Missouri Botanical Garden, and Forest Park. I am an avid Kentucky basketball fan and try not to miss any games. |
Selected Publications/Abstracts
- Sears, James J., Davis, Andrew A. Clinical Applications for Liquid Biopsy Assessment of Minimal Residual Disease in Breast Cancer. Current Breast Cancer Reports. 2023 May; doi: 10.1007/s12609-023-00489-z
- Rho, Shinji. Wang, Chris. Dehkordi, Seyed Hamed Hosseini. Sears, James J. Hu, Z Ian. Bleeding and thrombotic events in bevacizumab-treated patients with colorectal cancer on novel oral anticoagulants and antiplatelet medications. American Heart Journal Plus: Cardiology Research and Practice. 2023 Mar; doi: 10.1016/j.ahjo.2023.100283
- Sears, James J. Zishuo Ian Hu, Jing Xia Liu, Sammuel J. Ballentine. Efficacy of adjuvant fluoropyrimidine with or without oxaliplatin therapy in older adults with mismatch repair enzyme deficient stage III colorectal cancer. Poster Presented at ASCO GI Cancers Symposium San Francisco, CA
- Sears, James J., Swanner J., Fahrenholtz CD., Snyder C., Rohde M., Levi-Polyachenko N, Singh R. Combined Photothermal and Ionizing Radiation Sensitization of Triple-Negative Breast Cancer Using Triangular Silver Nanoparticles. International Journal of Nanomedicine. 2021 Feb; 16:851-865. doi: 10.2147/IJN.S296513
- Swanner, Jessica. Fahrenholtz, Cale. Tenvooren Iliana. Bernish, Brian. Sears, James J. Hooker, Allison. Furdui, Christina. Alli, Elizabeth. Li, Wencheng. Donati, George. Cook, Katherine. Vidi, Pierre-Alexandre. Singh, Ravi. Silver Nanoparticles Selectively Treat Triple Negative Breast Cancer Cells without affecting non-malignant breast epithelial cells in vitro and in vivo. FASEB BioAdvances. 2019;00:1-22. doi: 10.1096/fba.2019-00021